181
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The effect of pitavastatin calcium on endothelial dysfunction induced by hypercholesterolemia

, , , , , , , , & show all
Pages 1463-1471 | Published online: 09 Jun 2011

Bibliography

  • Wassmann S, Hilgers S, Laufs U, Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002;22:1208-12
  • Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997;96:3264-5
  • Cave AC, Brewer AC, Narayanapanicker A, NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006;8:691-728
  • Morrow JD, Roberts LJ II. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996;51:1-9
  • Pedersen TR. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9
  • Blum A, Shamburek R. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 2009;203:325-30
  • Zhou Q, Liao JK. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des 2009;15:467-78
  • Serruys PW, de Feyter P, Macaya C, Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287:3215-22
  • Chang HJ, Chung J, Choi SY, Endothelial dysfunction in patients with exaggerated blood pressure response during treadmill test. Clin Cardiol 2004;27:421-5
  • Corretti MC, Anderson TJ, Benjamin EJ, International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65
  • Woodman RJ, Playford DA, Watts GF, Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol 2001;91:929-37
  • Taddei S, Virdis A, Ghiadoni L, Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002;62:265-84
  • Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363-8
  • Osto E, Matter CM, Kouroedov A, c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Circulation 2008;118:2073-80
  • Heitzer T, Yla-Herttuala S, Luoma J, Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996;93:1346-53
  • Wassmann S, Hilgers S, Laufs U, Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002;22:1208-12
  • Shishehbor MH, Brennan ML, Aviles RJ, Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003;108:426-31
  • Schupp N, Schmid U, Heidland A, Stopper H. Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis. Atherosclerosis 2008;199:278-87
  • Vergnani L, Hatrik S, Ricci F, Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability. Circulation 2000;101:1261-6
  • Erdei N, Toth A, Pasztor ET, High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am J Physiol 2006;291:H2107-15
  • Armitage ME, Wingler K, Schmidt HH, La M. Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. J Mol Med 2009;87:1071-6
  • Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005;109:217-26
  • Montuschi P, Barnes P, Roberts LJ II. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007;14:703-17
  • Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004;287:R1014-30
  • Lavi S, Prasad A, Yang EH, Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 2007;115:2621-7
  • Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-75
  • Lavi S, Yang EH, Prasad A, The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 2008;51:127-33
  • Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997;79:350-4
  • Perrault LP, Mahlberg F, Breugnot C, Hypercholesterolemia increases coronary endothelial dysfunction, lipid content, and accelerated atherosclerosis after heart transplantation. Arterioscler Thromb Vasc Biol 2000;20:728-36
  • Mugge A, Elwell JH, Peterson TE, Release of intact endothelium-derived relaxing factor depends on endothelium superoxide activity. Am J Physiol 1991;260:C219-25
  • Harrison DG. Endothelial function and oxidant stress. Clin Cardiol 1997;20(11 Suppl 2):11-17
  • Jenkins DJ, Kendall CW, Nguyen TH, Effect of plant sterols in combination with other cholesterol-lowering foods. Metabolism 2008;57:130-9
  • Behrendt D, Ganz P. Endothelial function: from vascular biology to clinical applications. Am J Cardiol 2002;90:40-8L
  • Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005;4:977-87
  • Wassmann S, Laufs U, Muller K, Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 2002;22:300-5
  • Vlachopoulos C, Aznaouridis K, Dagre A, Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects. Eur Heart J 2007;28:2102-9
  • Yagi S, Aihara K, Ikeda Y, Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency. Circ Res 2008;102:68-76

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.